<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        22-222-06
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2006
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ZAMUR 500 MG F- C TABLETS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CEFUROXIME AXETIL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        37.85
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Steiner" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Steiner
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            ACINO PHARMA AG
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01DC02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Zamur is an antibiotic that, when taken, kills infectious bacterial microorganisms. Zamur is suitable to treat of infections of:  the tonsils, the throat, the sinus, and the middle ear  the lungs or chest  the urinary tract  the skin and soft tissues.&nbsp;<br />&nbsp;<br />Zamur is also used to treat:</p><p dir="ltr"> Lyme disease (an infection spread by parasites called ticks)</p><p dir="ltr"> Genital infection&nbsp;<br /><br />&nbsp;It must not be taken unless prescribed by a doctor. Your doctor should test for the type of bacteria responsible for your infection and monitor their susceptibility to Zamur during the course of treatment.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">a. Do not take Zamur Zamur must not be taken in cases of known or suspected hypersensitivity to cephalosporin antibiotics. If you have &ndash; or suspect you have &ndash; an allergy to penicillin, you must inform your doctor. For example, an allergy or hypersensitivity can manifest as symptoms such as skin blotches, fever, asthma, shortness of breath, blood circulation problems, swelling of the skin (e.g. hives) and mucous membranes, rash or painful tongue.&nbsp;<br />&nbsp;<br />b. Take special care with&nbsp;<br />Your doctor must be informed if you have previously suffered from an allergy to penicillin or you are generally prone to allergies. &nbsp;<br />When experiencing difficulty breathing, tightness of the chest, swelling of the eyelids, face or lips, rash (red spots), skin swelling, hives or very severe diarrhea, or symptoms of liver inflammation or jaundice such as tiredness, weakness, malaise during treatment, loss of appetite, nausea, vomiting, yellowing of the eyes (conjunctiva), skin or discolored stools, you should tell your doctor immediately before proceeding with Zamur. If diarrhoea occurs, you must not take any medicines that prevent bowel peristalsis (bowel movements). Inform your doctor, if you have kidney dysfunction, may need to adjust the dose of Zamur. &nbsp;In patients with diabetes, urine sugar tests may show a false-positive result if methods based on copper reduction are used (e. g. Fehling, Benedict, Clinitest); enzyme tests should therefore be used. If the disorder being treated with Zamur is not cured or has not significantly improved after one pack, you should tell your doctor immediately. After your treatment is completed, please return the pack with any remaining contents to your doctor or pharmacist for proper disposal. Further information may be obtained from your doctor or pharmacist. These persons have the detailed prescribing information at their disposal.&nbsp;<br />&nbsp;<br />c. Taking other medicines Medications taken to treat excessive production of stomach acid may alter the effect of &nbsp;Zamur. If you are taking an oral contraceptive (the pill), it may become less effective during treatment with antibiotics. This also applies to Zamur. For this reason, you should take additional&nbsp;contraceptive measures. Please tell your doctor or pharmacist if you are taking or using the following medicines: strong water-repellent medicines (diuretics), medicines used to treat gout that contain probenecid, medicines that reduce acidity in the stomach, oral contraceptives or other antibiotics (in particular antibiotics from the group of so-called aminoglycosides). Tell your doctor or pharmacist if you  suffer from other illnesses  have any allergies or  are taking any other medicines (including those purchased without a prescription). Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.&nbsp;<br />&nbsp;<br />d. Pregnancy and breast-feeding&nbsp;<br />&nbsp;<br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Zamur should not be used during pregnancy unless clearly necessary.&nbsp;<br />&nbsp;<br />e. Driving and using machines This medicine may cause dizziness, affecting the ability to react, drive, and use tools or machines. &nbsp;<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Always take Zamur exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. The usual duration of treatment is 7 (5-10) days, depending on the severity and course of the infection. Always keep to the dosage and length of treatment stated by your doctor and do not stop treatment under any circumstances without your doctor&rsquo;s consent. Zamur should be taken with food. Due to their bitter taste, the film-coated tablets should be swallowed whole with liquid. Adults and adolescents over 12 years of age Normally 1 &times; 250 mg film-coated tablet every 12 hours (morning and evening). For certain infections (otitis media and severe infections): 1 &times; 500 mg film-coated tablet every 12 hours (morning and evening). Lyme disease: 2 x daily (every 12 hours) 500 mg for 20 days. Uncomplicated gonorrhoea: one single dose of 1 g.&nbsp;&nbsp;<br />&nbsp;<br />Children aged 5 years and older (weighing at least 15 kg) up to 12 years of age: Normally 125 mg = &frac12; &times; 250 mg film-coated tablet every 12 hours (morning and evening). In children aged 5 years and older (weighing at least 20 kg) up to 12 years of age, Zamur filmcoated tablets can be used to treat middle-ear infections or severe infections. For middle-ear infections or severe infections, the dosage is 1 &times; 250 mg film-coated tablet, twice daily. This dosage must not be exceeded. Children under 5 years of age Zamur film-coated tablets are not suitable for treating children under 5 years of age. In some cases, the doctor may prescribe a different dosage for you. Do not change the prescribed dosage yourself. If you think that the effect of the medicine is too weak or too strong, talk to your doctor or pharmacist.&nbsp;<br />&nbsp;<br />If you take more Zamur than you should&nbsp;<br />If you take too much Zamur you may have cerebral disorders, which may manifest as seizures. Don&#39;t delay. Contact your doctor or your nearest hospital emergency department immediately. If possible, show them the Zamur pack. &nbsp;<br />If you have any further questions on the use of this product, ask your doctor or pharmacist.&nbsp;<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Like all medicines, Zamur can cause side effects, although not everybody gets them The following side effects may occur when taking Zamur: Common: fungal infections (such as oral thrush), headache, dizziness, gastrointestinal disorders such as diarrhea, abdominal pain and nausea. Uncommon: vomiting, rashes. Rare: severe diarrhea (see also &quot;Take special care with&quot;). Very rare: heartburn, jaundice, hepatitis, itching, nettle rash, severe rash, allergic reactions, or even anaphylactic shock (see also &quot;Take special care with&quot;). Also, changes in the numbers of white or red blood cells and platelets, prolonged bleeding times, and liver abnormalities have been reported. If one or more of the following symptoms occur, stop taking Zamur and inform your doctor as soon as possible: Severe nausea, severe diarrhoea or severe stomach pain, bleeding from the anus, initial yellowing of the skin or eyes.&nbsp;&nbsp;<br />&nbsp;<br />If you develop breathing difficulties, tightness in the chest, swelling of the eyelids, face or lips, rash (red spots), skin swelling or hives (signs of hypersensitivity/allergy), you should tell your doctor immediately and not continue taking Zamur unless expressly instructed to do so by the doctor.&nbsp;<br />&nbsp;<br />Some patients may get a high temperature (fever), chills, headache, muscle pain and skin rash while being treated with Zamur for Lyme disease. This is known as the Jarisch-Herxheimer reaction. Symptoms usually last a few hours or up to one day.&nbsp;<br />&nbsp;<br />Other side effects which may occur when taking Zamur:&nbsp;<br />&nbsp;<br />Common side effects (may affect up to 1 in 10 people)&nbsp;<br />&nbsp;<br /> an increase in a type of white blood cell (eosinophilia)  an increase in liver enzymes (ALT [SGPT], AST [SGOT], LDH)&nbsp;<br />&nbsp;<br />Uncommon side effects (may affect up to 1 in 100 people)  positive Coombs&rsquo; test &nbsp; a decrease in the number of blood platelets (cells that help blood to clot) &nbsp; a decrease in the number of white blood cells (leukopenia, neutropenia) &nbsp; an increase in liver tests (alkaline phosphatase, bilirubin)&nbsp;<br />&nbsp;<br />Rare side effects (may affect up to 1 in 1,000 people)  urticaria, pruritus (itching)&nbsp;<br />&nbsp;<br />Very rare side effects (may affect up to 1 in 10,000 people)  haemolytic anaemia (red blood cells destroyed too quickly) &nbsp;<br />&nbsp;<br />&nbsp;<br />If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.&nbsp;<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Keep out of the reach and sight of children. &nbsp;Do not store above 30 &ordm;C. Zamur may be used only up to the date marked with &ldquo;EXP&rdquo; on the pack. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.&nbsp;<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">The active substance is cefuroxime as cefuroximum axetil.&nbsp;</p><p dir="ltr">The other ingredients are: Table core: croscarmellose sodium, crospovidone, sodium laurilsulfate, castor oil, hydrogenated, methylcellulose, silica, precipitated. Film-coating: hypromellose, cellulose, microcrystalline, macrogol 8 stearate, talcum, titanium dioxide.&nbsp;<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Film-coated tablets (with a score line) of 250 mg and 500 mg cefuroxime (as 300.72 mg and 601.44 mg cefuroxime axetil). Zamur 250 mg, film-coated tablets (with a score line): 10, 14 and 10x14 Zamur 500 mg, film-coated tablets (with a score line): 10, 14 and 10x14. Not all presentations may be marketed. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Manufactured by Steiner, Berlin, Germany for Acino Pharma AG, Liesberg, Switzerland.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Jan 2019 
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="ltr">&nbsp;<br />زامور ن عبارة ع اد ح مضوي يل يقت ه الكائنات الحية الدقيقة البكتيرية المعدية عند تناول .ون يكور زام ﻼج ا لع ً مناسب حاﻻت العدوى التﱠالية: &nbsp; عدوى اللوزتين، الحلق، الجيوب اﻷنفية، واﻷذن الوسطى  &nbsp;عدوى الرئتين أو الصدر  &nbsp;المسالك البولية  &nbsp;الجلد واﻷنسجة الرخوة <br />&nbsp;<br />&nbsp;: ا زامور لعﻼج ً م أيض َ خد َ ست ُي .( مرض ﻻيم )وهي عدوى تنتشر عن طريق طفيليات تسمى القراد  . العدوى التناسلية <br />&nbsp;<br />&nbsp;يجب عدم تناوله ما لم يتم وصفه من قبل الطبيب. يجب أن يقوم طبيبك باختبار نوع البكتيريا المسؤولة عن العدوى لديك ومراقبة مدى حساسيتها تجاه ور زام ﻼل خ فترة العﻼج. &nbsp;&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="ltr">&nbsp;<br />أ. &nbsp;ﻻ تتنﺎول زامور&nbsp;<br />&nbsp;<br />يجب عدم تناول ور زام ن في الحاﻻت المصابة أو مشتبه في إصابتها بفرط الحساسية تجاه المضادات الحيوية م السيفالوسبورين .ب إذا كنت تعاني من حساسية أو كان لديك شك في أنك تعاني من حساسية تجاه البنسيلين، يج عليك إبﻼغ طبيبك .ن الم على سبيل المثال، من مكأن ت ع ظهر الحساسية أو فرط الحساسية في هيئة أعراض مثل بق الجلد والحمى والربو وضيق النفس ومشاكل الدﱠورة الدﱠموية وتورم الجلد )رى على سبيل المثال، ش)ا أرتكاري (( واﻷغشية المخاطية، طفح جلدي أو ألم باللسان.&nbsp;<br />&nbsp;<br />ب. &nbsp;ﺎ مع ا خﺎص ً توخ حذر يجب إبﻼغ طبيبك إذا كنت قد عا ت ً ني مسبق فة ا من حساسية تجاه البنسيلين أو إذا كنت من المعرضين بص عامة لﻺصابة بحساسية . عند اﻹصابة بصعوبة التﱠنفس، ضيق الصدر، تورﱡم الجفون أو الوجه أو الشفتين، طفح جلدي )راء ،( بقع حم تورم الجلد، شرى )ا أرتكاري (د أو أو إسهال شديد جدا، أو أعراض التهاب الكب الي ان رق عف، مثل تعب، ض الشعور بالضيق أثناء العﻼج، فقدان الشهية، غثيان، قيء، اصفرار العينين )ة الملتحم(د أو ، تغير لون الجل ا قبل بدء العﻼج ب ور ً تغير لون البراز، فيجب عليك حينئذ إبﻼغ طبيبك فور زام. في حالة حدوث إسهال، يجب عليك عدم تناول أية أدوية تمنع تمعج )حركة دود ﱠة ي (اﻷمعاء )حركة اﻷمعاء.( أبلغ طبيبك إذا كنت تعاني من قصور كلوي، فقد تكون بحاجة إلى تعديل جرعة زامور. &nbsp;ظهر اختبارات سكر البول نتيجة إيجابية كاذبة إذا تم استخدام ُ قد ت ،يِ في المرضى الذين يعانون من مرض السﱡكﱠر أساليب تستند إلى الحد من النحاس ) عل ب ى سيل ال المث :ت محلول فيهلنغ، محلول بنديكت، طريقة كلينتيس(ذلك ؛ ل يجب استخدام اختبارات اﻹنزيمات. إذا لم يتم شفاء اﻻضطراب الذي يتم عﻼجه ب ور زام ار أو لم يتحسن بشكل ملحوظ بعد عبوة واحدة، يجب عليك إخب طبيبك على الفور. رجى إعادة العبوة مع أي مكو ات ُ ي ، بعد نهاية عﻼجك نا متبقية إلى طبيبك أو الصيدلي الخاص بك للتﱠخلص منه بشكل مناسب. قد يتم الحصول على مزيد من المعلو ا مك ت من طبيبك أو الصيدلي الخاص ب .ديهم المعلو فهؤﻻء اﻷشخاص لا مت الوصفية المفصلة للتﱠخلص من اﻷدوية.&nbsp;<br />&nbsp;<br />ت. &nbsp;ى ل اﻷدوية اﻷخر ُ تنﺎو<br />&nbsp;<br />غير اﻷدوية التي يتم تناول ا ل ُ قد ت هأثير عﻼج فرط إفراز حمض المعدة من تور زام. &nbsp;تتناولين إحدى وسائل منع الحمل عن طريق الفم )ل ِ إذا كنت حبوب منع الحم(ﻼج صبح أقل فعالية أثناء الع ُ ، فقد ت بالمضادات الحيوية . ا على زامور .ل ً ينطبق ذلك أيض . اتخاذ تدابير إضافية لمنع الحم ِ يجب عليك ، لهذا السبب ُ ي ى رجﻼغ إب ة الطبيب أو الصيدلي الخاص بك إذا كنت تتناول أو تستخدم اﻷدوية التﱠالي :اردة لل اﻷدوية القوية الطا مء )ول رات الب(ن ِ د ُم ، اﻷدوية المستخدمة لعﻼج مرض النﱠقرس التي تحتوي على بروبنيسيد، اﻷدوية التي تخفض م الحموضة في المعدة، وسائل منع الحمل عن طريق ا م أ لفو الم رى ضادات الحيوية اﻷخ)وص وعلى وجه الخص .( وزيدات ُ ليك ْ وج ُ سمى اﻷمين ُ المضادات الحيوية من المجموعة التي ت أخبر طبيبك أو الصيدلي الخاص بك إذا كنت &nbsp; تعاني من أمراض أخرى &minus; &nbsp;لديك أية حساسية أو &minus; .( تتناول أية أدوية أخرى )بما في ذلك اﻷدوية التي يتم الحصول عليها بدون وصفة طبية &minus; ا أية أدوية أخرى، ب ا ً رجى إبﻼغ طبيبك أو الصيدلي الخاص بك إذا كنت تتناول أو تناولت مؤخر ُي م ي ف ذلك اﻷدوية التي حصلت عليها دون وصفة طبية.&nbsp;<br />&nbsp;<br />ث. &nbsp;ﱠة الحمل والرضﺎعة الطبيعي&nbsp;<br />&nbsp;<br />إذا كنت اعة رضعين رض ُ أو ت ً حامﻼ ة طبيعي ول ع ، أو تظنين أنك حامل، أو تخططين للحص لى طف ل، اس يري تش طبيبك أو الصيدلي الخاص بك قبل تناول هذا الدﱠواء. دم يجب عاول تن اك زامور أثناء فترة الحمل إﻻ إذا كانت هن ضرورة ملحة. &nbsp; &nbsp; ج. &nbsp;القيﺎدة واستخدام اﻵﻻت&nbsp;<br />&nbsp;<br />سبب هذا الدﱠواء دوخة مما ﻵ ُ قد ي &nbsp;. القيادة واستخدام اﻷدوات أو ا ﻻت ، ؤثر على القدرة على اﻻستجابة ُي</p><p dir="ltr">&nbsp;<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="ltr">تناول زامور دائ م كما أخبرك طبيبك بالضبط. &nbsp;.اً يجب مراجعة طبيبك أو الصيدلي الخاص بك إذا لم تكن متأكد (ا ١٠-٥)٧ عتادة هي ُ مدة العﻼج الم . ا لشدة العدوى ومدته ً وفق ، أيام التزم دائ ا م بالجرعة وطول مدة العﻼج التي ذكرها طبيبك وﻻ تتوق ن ف عﻼ العروف ج تحت أي ظرف من الظ دون موافقة طبيبك. &nbsp;. ل زامور مع الطعام ُ يجب تناو يجب بلع اﻷقراص المغلﱠفة كاملة ببعض السوائل لمذاقها المر. &nbsp; سنة فأكبر ١٢البالغون والمراهقون البالغون من العمر ل ٢٥٠ &times;١ عادة اعة ١٢ مجم قرص مغلف ك ً ) س &nbsp;.( ا ومساء ً صباح بالنسبة لحاﻻت ع دوى م ة عين)اب اﻷذن الته ً )ساعة ١٢مجم قرص مغلف كل ٥٠٠ &times; ١١ :(الوسطى وحاﻻت العدوى الشديدة .( ا ومساء ً صباح ا x٢ :مرض ﻻيم &nbsp;يوما ٢٠ ساعة (لمدة ١٢ مجم )كل ٥٠٠ يومي &nbsp;جم. ١السيﻼن غير معقدة: جرعة واحدة من &nbsp;: عاما ١٢ كجم على اﻷقل( وحتى ١٥ سنوات فأكبر )ممن تبلغ أوزانهم ٥ اﻷطفال من سن ً )ساعة ١٢مجم قرص مغلف كل ٢٥٠ &times;٢/١ =مجم١٢٥عادة &nbsp;.( ا ومساء ً صباح أكبر ٥ في اﻷطفال بعمر سنوات ف)م ل ٢٠ ممن تبلغ أوزانه كجم على اﻷق (ى عا ا ١٢ حت متخدام ، من الممكن اس زامور ة أقراص مغلﱠفة لعﻼج عدوى اﻷذن الوسطى أو حاﻻت العدوى الشديد. بالنسبة لحاﻻت عدوى اﻷذن الوسطى أو حاﻻت العد ة رتين ٢٥٠ &times;١ وى الشديدة، تبلغ الجرع مجم قرص مغلف، م يوميا .يجب عدم تجاوز هذه الجرعة. &nbsp;أعوام٥اﻷطفال أقل من زامور ع . سنوات ٥ أقراص مغلﱠفة غير مناسب لعﻼج اﻷطفال الذين تقل أ مارهم عن في بعض الحاﻻت، قد يصف لك الطبيب جرعة مختلفة. ﻻ تغير الجرعة الموصوفة من تلقاء نفسك .ى إذا كنت تظن أن تأثير الدﱠواء ضعيف جدا أو قوي جدا، فتحدﱠث إل طبيبك أو الصيدلي الخاص بك.&nbsp;<br />&nbsp;<br />إذا تنﺎولت كمية من زامور أكثر ممﺎ يجب&nbsp;<br />إذا تناولت كمية كبيرة من ور زام طرابات د صاب باضما د ُ فقد ت غية، التي قنجية تظهر في هيئة نوبات تش .ﻼ ف تتأخر .ك ا بطبيبك أو الصيدلي الخاص بك، أو قسم الطوارئ بأقرب مستشفى إلي .وة ً اتصل فور أظهر لهم عب زامور إذا أمكن .&nbsp;<br />إذا كانت لديك أية أسئلة إضافية حول استخدام هذا المنتج، فاستشر طبيبك أو الصيدلي الخاص بك.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="ltr"><br />&nbsp;سبب زامور ع ُ قد ي ، مثله مثل كافة اﻷدوية . على الرﱠغم من عدم حدوثها لدى الجمي ، ا جانبية ً آثار قد تحدث اﻵثار الجانبية التﱠالية عند تناول زامور: شائعة :ة حاﻻت العدوى الفطري)وي ق الفم َ مثل السﱡﻼ (ل والصداع والدوخة واضطرابات الجهاز الهضمي مث : اﻹسهال وألم ان البطن والغثي. غير شائعة :دي القيء والطفح الجل. نادرة :إسهال شديد )م ا قس&quot; :ا مع ً انظر أيض .(&quot; ا خاص ً توخ حذر نادرة جدا :ة الحموض)ؤاد (اعﻼت ُ ة الف َقْرُح ، يرقان، التهاب الكبد، الحكة، طفح القراص، طفح جلدي شديد، تف حساسية أو حتى صدمة تأقية )م ا قس&quot; :و ً انظر أيض تع .(&quot; ا خاصا م ً خ حذر ا عن، تغيرات في تعداد خﻼيا الدﱠم البيضاء أو خﻼيا الدﱠم الحمراء والصفائح الدﱠموية، إطالة زمن ً تم اﻹبﻼغ أيض النزف وتشوهات الكبد. &nbsp;: توقف عن تناول زامور وأبلغ طبيبك في أقرب وقت ممكن ، في حالة اﻹصابة بأحد اﻷعراض التﱠالية أو أكثر غثيان شديد، إسهال شديد أو ألم شديد بالمعدة، نزيف من الشرج، اصفرار أولي للجلد أو العينين. صبت بصعوبات في التنفس، ضيق في الصدر، تورﱡم الجفون أو الوجه أو الشفتين، طفح جلدي )راء ُ إذا أ ،( بقع حم تورم الجلد أو شرى )ا أرتكاري) (عﻼ ا مية ت على اﻹصابة بفرط الحساس/ ي الحساسة(ﻼغ ، فيجب عليك حينئذ إب . ا وعدم مواصلة تناول زامور ما لم يخبرك طبيبك بذلك صراحة ً طبيبك فور<br />&nbsp;</p><p dir="ltr">&nbsp;<br />صاب بعض المرضى بارتفاع درجة الحرارة )ى ُ قد ي حم(اء ، قشعريرة، صداع، ألم عضلي وطفح جلدي أثن عﻼجهم من مرض ﻻيم ب ور زام .اريش رِ - عرف هذا باسم تفاعل ي ُي هايم .ادة ْسِ يك ِه ع م ا ع تدوم اﻷعراض لبض ساعات أو تصل إلى يوم واحد. &nbsp; اﻵثار الجانبية اﻷخرى التي قد تحدث عند تناول زامور&nbsp;<br />&nbsp;<br />اﻵثﺎر الجﺎنبية الشﱠﺎئعة )ي (أشخاص١٠من كل ١ ؤثر ف ما يصل إلى ُ قد ت<br />&nbsp;<br /> &nbsp;زيادة في نوع من خﻼيا الدﱠم البيضاء)ت ( يﱠا ِ وزين ُ كثرة خﻼيا الي ي إنزي  زيادة فا مد ت الكب)ن ة ﻻنيني]ك َ اﻷ ِ مين َ ة اﻷ َلِ اق ِ [ روفي ْيَ ب ِ ين الغلوتاميك ِمَ ة أ َلِ اق َ إنزيم ن مين َ ة اﻷ َلِ ناق ، اﻷسبارتية ]ناقلة أمين الجلوتاميك أوكسالو-أسيتيك[ت .( ين الﻼكتا ِجُ رو ْدِ ة هي َعِ إنزيم ناز ،<br />&nbsp;<br />اﻵثﺎر الجﺎنبية غير الشﺎئعة )ي (شخص١٠٠من كل ١ ؤثر ف ما يصل إلى ُ قد ت &nbsp;نتيجة إيجابية في اختبار كومبس   &nbsp;انخفاض تعداد الصفائح الدﱠموية في الدﱠم)ﱠم &nbsp;.( ساعد على تخثر الد ُ الخﻼيا التي ت  &nbsp;انخفاض عدد خﻼيا الدﱠم البيضاء)ت &nbsp;.( ﻻِدَ قلة خﻼيا الع ، ضاء ْ الدﱠم البي ِ يﱠات َ قلﱠة كر زيادة في نتائج اختبارات الكبد )ر  .( البيلي وبين ،يِوَلَ فاتيز الق ْسُ الفو<br />&nbsp;<br />اﻵثﺎر الجﺎنبية النﱠﺎدرة )ي (شخص١٠٠٠ من كل ١ ؤثر ف ما يصل إلى ُ قد ت . أرتكاريا، حكة <br />&nbsp;<br />اﻵثﺎر الجﺎنبية النﱠﺎدرة جدا )ي (شخص١٠٠٠٠من كل ١ ؤثر ف ما يصل إلى ُ قد ت  &nbsp;فقر الدﱠم اﻻنحﻼلي)ة انحﻼل خﻼيا الدﱠم الحمراء بسرعة كبير ( &nbsp; إذا أصبح أيﱞ من اﻵثار الجانب ﻼغ رجى إب ُ في ، أو إذا ﻻحظت أية آثار جانبية غير الواردة في هذه النﱠشرة ،اً ية خطير طبيبك أو الصيدلي الخاص بك.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="ltr">&nbsp;<br />&nbsp; . ا عن متناول و رؤية اﻷطفال ً يحفظ بعيد .درجة مئوية٣٠ﻻ يخزن في درجة حرارة تتعدى &nbsp;. &quot;على العبوة EXP&quot; من الممكن استخدام زامور فقط حتى تاريخ انتهاء الصﻼحية المحدد بكلمة يجب عدم التﱠخلص من اﻷدوية عن طريق مياه الصرف أو مع المخلفات المنزلية .اص استشر الصيدلي الخ بك عن كيفية التﱠخلص من اﻷدوية التي لم تعد بحاجة إليها .ح . ساعد هذه اﻹجراءات على ماية البيئة ُ ست<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="ltr">الما ل دة الفعﱠالة هي سيفيوروكزيم في هيئة سيفيوروكزيم أكسيتي. المكونات اﻷخرى هي: المحتوى الدﱠاخلي للقرص :وديوم، كروسكارميلوز الصوديوم، كروسبوفيدون، لوريل سلفات الص زيت الخروع المهدرج، ميثيل السليلوز، سيليكا مرسبة. م ٨ الغﻼف :هيبروميلوز، سليلوز، دقيق التبلور، ماكروجول&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="ltr">أقراص مغلﱠفة )يم بها خط تقس (ا م ٢٥٠ به يفيوروكزيم ٥٠٠ مج مجم س)ة ٣٠٠ في هيئ م و ٫٧٢ ٦٠١ مج ٫٤٤ مجم سيفيوروكزيم أكسيتيل.( &nbsp; ٢٥٠ زامور &nbsp; ١٤&times;١٠ &nbsp;و ١٤ , ١٠ :( أقراص مغلﱠفة)بها خط تقسيم ، مجم &nbsp;٥٠٠ زامور &nbsp; ١٤&times;١٠ &nbsp;و ١٤ , ١٠ :( أقراص مغلﱠفة)بها خط تقسيم ، مجم قد ﻻ يتم تسويق جميع العبوات</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>تم التﱠصنيع بمعرفة شتاينر، برلين، ألمانيا لصالح شركة أسينو فارما إيه جي، ليزبيرج، سويسرا.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            يناير  2019
 

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Zamur 250 mg, film-coated tablets 
 
Zamur 500 mg, film-coated tablets 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Active ingredient 
Cefuroxime as cefuroxime axetil. Excipients 
Excipients for film-coated tablets. 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablets (with a score line) of 250 mg and 500 mg cefuroxime (as 300.72 mg and 601.44 mg cefuroxime axetil). 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Zamur is indicated in the following infections caused by cefuroxime-sensitive microorganisms: Upper respiratory tract: tonsillitis, pharyngitis, otitis media, sinusitis. Lower respiratory tract: acute bronchitis and acute exacerbations of chronic bronchitis, pneumonia.&nbsp;<br />Urinary tract: pyelonephritis, cystitis, urethritis.&nbsp;<br />Skin and soft tissue: furunculosis, pyoderma, impetigo. &nbsp;<br />Gonorrhoea: acute uncomplicated urethritis and cervicitis.&nbsp;<br />Lyme&rsquo;s disease: stage I, erythema chronicum migrans with possible transient joint symptoms or transitory and limited neurological reactions. Official recommendations on the appropriate use of antibiotics should be followed, particularly recommendations for use regarding the prevention of increased resistance to antibiotics.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">The usual duration of treatment is 7 (5-10) days, depending on the severity and course of the infection.&nbsp;<br />&nbsp;<br />To ensure optimal absorption, Zamur should be taken with meals. Due to their bitter taste, the film-coated tablets should not be chewed or crushed and are therefore unsuitable for children below 5 years of age. Usual dosage&nbsp;<br />Adults and children over 12 years&nbsp;<br />Standard dosage: 250 mg twice daily (every 12 hours).&nbsp;<br />Mild to moderate lower respiratory tract infections: 250 mg twice daily (every 12 hours).&nbsp;<br />Severe lower respiratory tract infections: 500 mg twice daily (every 12 hours).&nbsp;<br />Uncomplicated gonorrhoea: one single dose of 1 g.&nbsp;<br />Lyme&rsquo;s disease: 500 mg twice daily (every 12 hours) for 20 days.&nbsp;<br />Alternative dosage&nbsp;<br />- Mild to moderate community-acquired pneumonia: 1.5 g cefuroxime sodium IV or IM twice daily for 48 &ndash; 72 hours, followed by 500 mg Zamur orally twice daily for 7 &ndash; 10 days. - Acute exacerbations of chronic bronchitis: 750 mg cefuroxime sodium IV or IM twice daily for 48 &ndash; 72 hours, followed by 500 mg Zamur orally twice daily for 5 &ndash; 10 days. The time for switching from parenteral to oral treatment is dependent on the severity of infection, the patient&rsquo;s clinical condition and microbial sensitivity. If no clinical improvement has occurred within 72 hours, parenteral treatment must be continued. Children aged 5 to 12 years:&nbsp;<br />Standard dosage:&nbsp;<br />For most infections, the dosage for children aged 5-12 years weighing at least 15 kg is &nbsp;125 mg (2 x &frac12; film-coated tablet) twice daily (every 12 hours), up to a maximum daily dose of 250 mg. Otitis media or serious infection in children from 5 years of age weighing at least 20 kg: 250 mg twice daily (every 12 hours). Maximum daily dose: 500 mg. Children under 5 years:&nbsp;<br />It is not possible to treat children under 5 years with the pharmaceutical formulations available for Zamur.&nbsp;</p><p dir="ltr">&nbsp;<br />Dosage in impaired renal function&nbsp;<br />Cefuroxime is mainly excreted via the kidneys.&nbsp;<br />In patients with significant renal impairment (creatinine clearance below 30 mL/min), it is recommended that the cefuroxime dosage be reduced on account of the slower elimination (see table below). &nbsp;</p><p dir="ltr"><br />Creatinine clearance : T&frac12; (hours) : Recommended dosage&nbsp;<br />&ge;30 mL/min/1.73 m2 :&nbsp;1.4-2.4 : No dose adjustment required (usual dose of 125 mg to 500 mg twice daily)&nbsp;<br />10&ndash; 29 mL/min/1.73 m2 :&nbsp;&nbsp;4.6 : Standard single dose, every 24 hours&nbsp;<br />&lt;10 mL/min/1.73 m2 : 16.8 : Standard single dose, every 48 hours&nbsp;<br />On haemodialysis : 2-4 :&nbsp; After every dialysis session, an additional standard single dose should be administered.&nbsp;<br />&nbsp;<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Zamur is contraindicated in cases of confirmed hypersensitivity to cephalosporins. The possibility of cross-allergy should be considered in cases of penicillin hypersensitivity. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">In general, caution is advised when administering beta-lactam antibiotics to patients who are susceptible to allergic reactions. As with other antibiotics, administration may result in increased growth of Candida. With prolonged administration, increased growth of non-sensitive microbes (e.g. enterococci, Clostridium difficile) may also occur, which may necessitate discontinuation of treatment. Close patient observation is therefore essential. If a superinfection occurs during treatment, appropriate measures must be taken.&nbsp;<br />The onset of diarrhoea during or after treatment with Zamur, especially if it is severe, persistent and/or bloody, may be a symptom of infection with Clostridium difficile. Its most severe form is pseudomembranous colitis. If any such complication is suspected, treatment with Zamur must be discontinued immediately and the patient should be thoroughly examined to initiate, if necessary,&nbsp;</p><p dir="ltr">&nbsp;<br />specific antibiotic therapy (e.g. metronidazole, vancomycin). The use of antiperistaltic agents is contraindicated in this clinical situation.&nbsp;<br />In cases of impaired renal function, the Zamur dosage must be adjusted to the degree of renal insufficiency (see &ldquo;Dosage in impaired renal function&rdquo;). Caution is advised when combining high-dose cephalosporins with potent diuretics and/or aminoglycosides, as this might adversely affect renal function (see &ldquo;Interactions&rdquo;). During treatment, renal function should be constantly monitored in patients on combination therapy, in patients with pre-existing renal damage and generally in elderly patients. In case of (epilepsy-like) seizures (see &ldquo;Overdose&rdquo;), the usual appropriate emergency measures are indicated (e.g. maintaining airway patency and administration of anticonvulsants). In association with cefuroxime treatment for Lyme&rsquo;s disease, occurrence of a Jarisch- Herxheimer reaction was observed in approximately 17% of patients. This reaction is a direct consequence of the bactericidal action of cefuroxime on Borrelia burgdorferi, the spirochete which causes Lyme&rsquo;s disease. The patient should be assured that this is a usual and normally transient consequence of antibiotic treatment for Lyme&rsquo;s disease. Patients must be informed that taking this medicinal product can cause dizziness and may thereby impair the ability to drive and use machines (see sections &ldquo;Effects on ability to drive and use machines&rdquo; and &ldquo;Undesirable effects&rdquo;).&nbsp;<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Cephalosporin antibiotics should only be given with extreme caution in combination with aminoglycosides and potent diuretics such as furosemide, as these combinations can have an adverse effect on renal function.&nbsp;<br />Taking medicines that reduce gastric acid levels may decrease the bioavailability of Zamur and offset the normally increased rate of absorption after a meal. Probenecid leads to a reduction in the renal clearance of Zamur, thereby increasing concentrations of Zamur and prolonging its residence time within the body. As with other antibiotics, cefuroxime can adversely affect the intestinal flora, which can lead to reductions in oestrogen absorption and efficacy of combined oral contraceptives.&nbsp;<br />Bacteriostatic agents can interfere with the bactericidal action of cephalosporins.&nbsp;<br />Antagonism with cefoxitin, imipenem and chloramphenicol has been demonstrated in rare cases. The clinical relevance of these in vitro results is not known.&nbsp;</p><p dir="ltr">&nbsp;<br />For blood/plasma glucose determination, enzymatic methods (glucose oxidase or hexokinase method) should be used, as interference has been observed in reduction tests. To determine creatinine, the alkaline picrate assay (Jaff&eacute; reaction) should be used.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Pregnancy&nbsp;<br />Experimental studies revealed no indications of embryopathic or teratogenic effects. No controlled studies are available on pregnant women. Zamur should not be used during pregnancy unless clearly necessary.</p><p dir="ltr">Lactation&nbsp;<br />Small quantities of cefuroxime are excreted in human milk. Use during lactation is therefore not recommended.&nbsp;<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">This medicinal product can cause dizziness. Patients should therefore be warned that dizziness occurring while driving or using machines can affect their own safety and that of others.&nbsp;<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">The frequency categories stated below are estimates, as no appropriate data (e.g. from placebo-controlled studies) were available for calculating the incidence of most reactions. In addition, the incidence of adverse reactions associated with cefuroxime axetil may vary according to the indication. Data from large clinical studies were used to determine the frequency of very common to rare undesirable effects. Frequencies for all other undesirable effects (i.e. with an incidence of &lt; 1/10,000) mainly come from post-marketing reports and therefore refer to the reporting rate rather than actual frequency of occurrence. No data were available from placebo-controlled studies. In cases where incidence values were calculated from clinical study data, drug-related data (according to investigator assessment) were used. The following convention has been used for the classification of frequency: Very common &ge; 1/10; common &ge; 1/100 and &lt; 1/10; uncommon &ge; 1/1,000 and &lt; 1/100; rare &ge; 1/10,000 and &lt; 1/1,000; very rare &lt; 1/10,000. Infections and infestations Common: increased growth of Candida with long-term use.&nbsp;<br />Blood and lymphatic system disorders Common: eosinophilia.&nbsp;</p><p dir="ltr">&nbsp;<br />Uncommon: positive Coombs&rsquo; test, thrombocytopenia, leukopenia (occasionally very pronounced), neutropenia. Very rare: haemolytic anaemia.&nbsp;<br />Cephalosporins as a substance class tend to attach to the surface of red cell membranes and react with antibodies directed against the medicinal product, thus producing a positive Coombs&rsquo; test and, very rarely, haemolytic anaemia. Serological cross-matching may be affected. Immune system disorders&nbsp;<br />Hypersensitivity reactions including: Uncommon: rash including maculopapular or morbilliform exanthema. Rare: urticaria, pruritus (itching). Very rare: drug fever, serum sickness, anaphylaxis.&nbsp;<br />Nervous system disorders Common: headache, dizziness. Gastrointestinal disorders&nbsp;<br />Common: gastrointestinal disorders including diarrhoea, nausea, abdominal pain. Uncommon: vomiting.&nbsp;<br />Rare: pseudomembranous colitis (see &ldquo;Special warnings and precautions for use&rdquo;). Very rare: heartburn.&nbsp;<br />When treating Lyme&rsquo;s disease, there may be increased incidence of diarrhoea (around 10% in controlled studies), due to the prolonged duration of treatment (20 days). Hepatobiliary disorders&nbsp;<br />Common: transient elevations of liver enzyme values: (ALT [SGPT], AST [SGOT], LDH). Uncommon: transient increase in alkaline phosphatase. The bilirubin concentration may also rise temporarily. Very rare: jaundice (predominantly cholestatic jaundice), hepatitis. Skin and subcutaneous tissue disorders&nbsp;<br />Very rare: erythema exsudativum multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis (exanthema necrolysis).&nbsp;<br />See also Immune system disorders.&nbsp;<br />&nbsp;<br />To report any side effect(s): Saudi Arabia:&nbsp;</p><p dir="ltr">&nbsp;<br />The National Pharmacovigilance and Drug Safety Centre (NPC)  Fax: +966-11-205-7662  Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.  Toll free phone: 8002490000  E-mail: npc.drug@sfda.gov.sa  Website: www.sfda.gov.sa/npc&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Cases of overdose with cephalosporins can cause cerebral disorders, which may manifest as seizures. Anticonvulsant treatment may be indicated. Excessively high cefuroxime levels can be reduced by haemodialysis or peritoneal dialysis.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">ATC code: J01DC02&nbsp;<br />Mechanism of action&nbsp;<br />Cefuroxime axetil (1-acetoxyethylester of cefuroxime) is a semi-synthetic second- generation cephalosporin, which is effective when given orally. Cefuroxime may only be administered parenterally. Cefuroxime axetil, a prodrug, is converted in the body to the active metabolite cefuroxime, which exerts a bactericidal action by inhibiting cell wall synthesis. Zamur is stable against most &beta;-lactamases and is active in vitro against the following microorganisms. The prevalence of acquired resistance varies depending on the geographic region, as well as over time, and may be very high in certain species. Information on resistance in each specific region is useful, especially for the treatment of severe infections.&nbsp;<br />In vitro sensitivity of pathogens to cefuroxime&nbsp;<br />* Clinical efficacy of cefuroxime has been proven in clinical studies. + All methicillin-resistant Staphylococcus spp. are resistant to cefuroxime. Sensitive microorganisms&nbsp;<br />&nbsp;<br />Normally sensitive microorganisms: &nbsp; Gram-positive aerobes: &nbsp; Streptococcus pyogenes* (and other &beta;-haemolytic streptococci) &nbsp;&nbsp;</p><p dir="ltr">&nbsp;<br />Staphylococcus aureus *(methicillin-sensitive isolates) + coagulase-negative staphylococci (methicillin-sensitive isolates)&nbsp;<br />&nbsp;&nbsp;<br />Gram-negative aerobes: &nbsp; Haemophilus influenzae (incl. ampicillin-resistant strains)* &nbsp; Haemophilus parainfluenzae* &nbsp; Moraxella catarrhalis* &nbsp; Spirochetes: Borrelia burgdorferi* Species in which acquired resistance may pose a problem Gram-positive aerobes: Streptococcus pneumoniae* Gram-negative aerobes: Citrobacter spp. excl. C. freundii Enterobacter spp. excl. E. aerogenes and E. cloacae Escherichia coli* Klebsiella spp. incl. K. pneumoniae* Neisseria gonorrhoea* (penicillinase-and non-penicillinase-producing strains) Proteus mirabilis Proteus spp. excl. P. penneri and P. vulgaris Providencia spp. Gram-positive anaerobes: &nbsp; &nbsp;Clostridium spp. with C. difficile &nbsp; Peptostreptococcus spp. &nbsp;&nbsp;<br />Propionibacterium spp. &nbsp;&nbsp;<br />Gram-negative anaerobes: Bacteroides spp. excl. B. fragilis &nbsp; Fusobacterium spp. &nbsp; Naturally resistant species: Gram-positive aerobes: Enterococcus spp. incl. E. faecalis and E. faecium Listeria monocytogenes Gram-negative aerobes: Acinetobacter spp. Burkholderia cepacia&nbsp;</p><p dir="ltr">&nbsp;<br />Campylobacter spp. Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Morganella morganii Proteus penneri Proteus vulgaris Pseudomonas spp. incl. P. aeruginosa Serratia spp. Stenotrophomonas maltophilia Gram-positive anaerobes: Clostridium difficile Gram-negative anaerobes: Bacteroides fragilis Other microorganisms: &nbsp; Chlamydia species &nbsp; Mycoplasma species &nbsp; Legionella species &nbsp; It is recommended that a sensitivity test be carried out in infections caused by moderately sensitive microorganisms, so that possible resistance can be excluded. Sensitivity to cefuroxime can be determined via standardised procedures, as recommended for example by the Clinical and Laboratory Standards Institute (CLSI), using disc or dilution tests. The following parameters are recommended by the CLSI as sensitivity criteria:&nbsp;<br />&nbsp;Disc test (30 &micro;g) diameter (mm) Dilution test MIC (mg/L) Sensitive &ge;23 &le;4 Intermediate 15-22 8-16 Resistant &le;14 &ge;32&nbsp;<br />&nbsp;<br />Laboratory results in the dilution test or the standardised disc diffusion test should be interpreted according to the following criteria: Moderately sensitive microorganisms are sensitive at high dosage or when the infection is restricted to tissues and fluids in which high antibiotic levels are achieved. In vitro, synergistic or additive effects have been observed for cefuroxime with a number of bactericidal antibiotics, especially aminoglycosides.&nbsp;</p><p dir="ltr">&nbsp;<br />Antagonism with cefoxitin, imipenem and chloramphenicol has been demonstrated in rare cases. The clinical significance of these in vitro results is not known. As with other penicillins and cephalosporins, cross-resistance can occur within the same class of antibiotic.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Absorption&nbsp;<br />Following oral administration, cefuroxime axetil is absorbed from the gastrointestinal tract and rapidly hydrolysed in the intestinal mucosa. It enters the blood circulation as cefuroxime. Absorption is optimal when taken after meals. The absolute bioavailability of the film-coated tablets is 40-60% when taken with meals and 3040% when taken on an empty stomach. Peak blood levels are achieved after 2-3 hours, amounting to 2-3 mg/L after 125 mg, 4-6 mg/L after 250 mg, 5-8 mg/L after 500 mg and 9- 14 mg/L after 1 g when the film-coated tablets are taken with food. Distribution&nbsp;<br />The apparent volume of distribution after an oral dose is 17.4 L. Protein binding is 33-50%, depending on the assay method used. In pregnant women, small amounts of cefuroxime cross the placental barrier. Small amounts of cefuroxime are excreted in human milk. Metabolism&nbsp;<br />Following oral administration, cefuroxime axetil is rapidly hydrolysed by non-specific esterases in the intestines and blood. The axetil fraction is converted to acetaldehyde and acetic acid, while cefuroxime is excreted unchanged. Elimination&nbsp;<br />The serum half-life is 1-1.5 h. Cefuroxime is not metabolised and is excreted by glomerular filtration and tubular secretion. Within 12 hours, approximately 50% of the active substance is found in the urine.&nbsp;<br />&nbsp;<br />Kinetics of special patient groups Probenecid&nbsp;<br />Concomitant administration of probenecid increases the area under the plasma level/time curve by 50%. Renal impairment&nbsp;<br />The pharmacokinetics of cefuroxime have been studied in patients with various degrees of impaired renal function. The elimination half-life of cefuroxime increases with diminishing renal&nbsp;</p><p dir="ltr">&nbsp;<br />function; based on this, the recommendations for dose adjustment in this patient group are made (see Posology/Administration). In patients receiving haemodialysis, at least 60% of the total baseline amount of cefuroxime present in the body is removed during a 4-hour dialysis session. For this reason, an additional single dose of cefuroxime should be administered upon completion of the haemodialysis session.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">General toxicology&nbsp;<br />In animal studies, cefuroxime axetil has been shown to have only very low toxicity. There were no indications of target organ toxicity in repeated-dose studies with rats and dogs at dosages exceeding those in therapeutic use. Mutagenicity/carcinogenicity&nbsp;<br />Only negative findings were obtained for cefuroxime axetil in a standard series of in vitro tests and an in vivo micronucleus test in mice. As expected, the substance induced chromosomal aberrations in human lymphocytes under in vitro conditions. However, this property can also be observed with other beta- lactam antibiotics and there is no evidence to suggest that this indicates a carcinogenic potential. As cefuroxime axetil is used for short-term treatment only, no carcinogenicity studies have been conducted. Reproductive toxicology&nbsp;<br />Cefuroxime axetil showed no adverse effects on the fertility or peri/postnatal development of rats, or on the embryofoetal development of mice or rats, at dosages significantly exceeding those in therapeutic use.&nbsp;<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Table core: croscarmellose sodium, crospovidone, sodium laurilsulfate, castor oil, hydrogenated, methylcellulose, silica, precipitated. Film-coating: hypromellose, cellulose, microcrystalline, macrogol 8 stearate, talcum, titanium dioxide.&nbsp;<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Effect on diagnostic methods&nbsp;<br />During Zamur treatment, the direct Coombs&rsquo; test can become temporarily positive. This can&nbsp;</p><p dir="ltr">&nbsp;<br />affect serological cross-matching. Enzymatic methods (glucose oxidase or hexokinase method) should be used for blood/plasma glucose determination, as interference has been observed in reduction tests. To determine creatinine, the alkaline picrate assay (Jaff&eacute; test) should be used.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months 
Zamur may only be used until the date marked with “EXP” on the container. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Do not store above 30 &ordm;C.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">PVC/PVDC foil blisters or aluminium-foil / aluminium-foil blisters.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Zamur 250 mg, film-coated tablets (with a score line): 14 and 10x14 Zamur 500 mg, film-coated tablets (with a score line): 14 and 10x14 Not all presentations may be marketed.&nbsp;<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Acino Pharma AG, Liesberg, Switzerland 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jan 2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>